4-MeO-PCP (4-Methoxyphencyclidine) is a dissociative research chemical belonging to the arylcyclohexylamine class, primarily known for its action as an NMDA receptor antagonist. It shares structural similarities with PCP (phencyclidine) but is often described as having a smoother, more introspective effect profile. Researchers value its potential to induce states of depersonalization, sensory distortion, and altered consciousness, making it suitable for studying the neurochemical basis of dissociation.

• NMDA Receptor Antagonism: 4-MeO-PCP blocks NMDA glutamate receptors in the brain, leading to a reduction in excitatory neurotransmission. This disruption causes a detachment from sensory input and subjective reality, the hallmark of dissociative experiences.

• Arylcyclohexylamine Structure: Its chemical structure contains a cyclohexyl ring bonded to a piperidine and methoxy-substituted phenyl ring. These features are shared with compounds like ketamine and PCP, which contribute to its similar but distinct pharmacology.

• Reduced Stimulation vs. PCP: Compared to PCP, 4-MeO-PCP produces fewer stimulant-like effects and a less chaotic mental state, making it more favorable in controlled research environments.

• Psychotropic Properties: Users often describe a dreamlike state, altered perception of time and space, and emotional detachment, making it a point of interest in exploring consciousness and cognitive dissociation.

• Dose-Dependent Effects: At low doses, the effects are subtle and cognitive; higher doses produce deep disconnection from physical reality, often resembling out-of-body experiences.

• Pharmacological Versatility: Although NMDA receptor activity is primary, 4-MeO-PCP may weakly interact with dopamine and serotonin transporters, subtly influencing mood or cognition.

• Non-Medical Classification: It is not approved for medical use, and all effects have been observed only in non-clinical, experimental, or anecdotal settings.

The legal status of 4-MeO-PCP varies widely depending on the country, jurisdiction, and how local laws interpret analogues of controlled substances. While it may be legal or unregulated in some regions, others have explicitly banned it or consider it controlled under analogue legislation.

• United States: 4-MeO-PCP is not federally scheduled but may fall under the Federal Analogue Act if intended for human consumption. This makes its legal standing ambiguous and dependent on context.

• United Kingdom: 4-MeO-PCP is a Class B controlled substance, making its sale, possession, and distribution illegal.

• Canada: It may be controlled under analogue laws, especially if associated with substances like PCP or ketamine.

• European Union: Some EU countries, like Sweden and Germany, have added 4-MeO-PCP to their controlled substances lists, while others allow it in research contexts.

• Australia & New Zealand: Generally controlled under analogue provisions or explicitly banned depending on state or territory.

• Asia & Africa: Laws vary significantly; in many countries, it exists in a legal gray area but may be subject to import restrictions.

• Buyer Responsibility: It’s essential for buyers to verify local, regional, and national regulations before placing an order to avoid customs issues or legal consequences.

We take product purity seriously. At Psycho Plug, all 4-MeO-PCP sold is independently tested by certified laboratories to confirm its identity and composition, ensuring it meets the highest standards for research-grade material.

• ≥98% Purity Assurance: Every batch we sell is guaranteed to be at least 98% pure, confirmed through HPLC or GC-MS testing methods.

• Certificate of Analysis (CoA): Each shipment includes a batch-specific CoA, detailing chemical identification, purity level, and absence of contaminants.

• Third-Party Lab Testing: Testing is performed off-site by licensed chemical analysis partners, eliminating conflicts of interest and ensuring transparency.

• No Fillers or Additives: Our 4-MeO-PCP contains no cutting agents, binders, or solvents—only the pure compound in its verified form.

• Consistency Across Batches: We maintain a standardized sourcing process to ensure each batch matches previous quality levels.

• Contaminant-Free Guarantee: Products are screened for heavy metals, solvent residues, and unwanted byproducts that may result from poor synthesis.

• Packaging Integrity: Products are vacuum-sealed in sterile, moisture-resistant containers to maintain purity during transit and storage.

Although both 4-MeO-PCP and PCP belong to the same chemical family, their effects, risk profiles, and user experiences differ in meaningful ways. 4-MeO-PCP is often considered a less aggressive, more introspective alternative to PCP, with a reduced tendency for erratic behavior or overstimulation.

• Stimulant Effects: PCP is known to cause agitation, increased physical activity, and even aggression in some users. 4-MeO-PCP generally lacks these effects and is described as more mentally “smooth.”

• Potency and Dosage: PCP is more potent by weight and requires lower doses to achieve strong effects. 4-MeO-PCP usually requires higher doses to reach comparable intensity.

• Duration and Onset: Both have similar durations, but 4-MeO-PCP has a slower onset, making it more manageable in structured settings.

• Mental Clarity vs. Disruption: 4-MeO-PCP allows for greater mental clarity during dissociation, whereas PCP is often more chaotic and unpredictable.

• Legal and Cultural Perception: PCP carries a high stigma and is explicitly banned in most jurisdictions. 4-MeO-PCP, being less known, often exists in regulatory grey areas.

• Use in Research: 4-MeO-PCP is favored in research for its consistent effect profile and lower behavioral volatility.

• Neurochemical Interaction: While both act on NMDA receptors, PCP has stronger dopaminergic effects, contributing to its higher abuse and dependence potential.

Proper storage is essential to preserve the chemical integrity and stability of 4-MeO-PCP over time. Incorrect storage can result in degradation, contamination, or loss of potency, particularly in warm, humid environments.

• Cool, Dry Environment: Store 4-MeO-PCP in a temperature-controlled space, ideally below 25°C (77°F). Avoid places near heat sources or direct sunlight.

• Airtight Container: Use a sealed, airtight container to prevent moisture from entering and degrading the compound. Glass vials or thick polyethylene bags are ideal.

• Light Protection: UV light can degrade sensitive chemicals. Keep the container in a dark place or use amber-colored vials for added protection.

• Humidity Control: Include desiccant packs to absorb moisture and reduce relative humidity inside the container.

• Labeling: Clearly label all containers with product name, batch number, and date received to avoid mix-ups or expired use.

• Away from Children/Pets: Ensure the substance is stored in a secure location, inaccessible to minors or animals, in compliance with safety practices.

• Avoid Frequent Exposure: Minimize the number of times the container is opened. Repeated exposure to air and moisture can affect purity.

In research settings, 4-MeO-PCP is generally dosed with high caution due to its dissociative potency and nonlinear dose-response curve. A small increase in quantity can result in significantly stronger effects. Dosages vary depending on the route of administration and research objective but should always start low and increase incrementally if required.

• Threshold Dose (1–2 mg): At very low levels, subtle changes in perception, cognitive processing, or bodily awareness may be observed. These doses are often used in receptor binding studies or microdosing trials.

• Light Dose (3–5 mg): May produce mild dissociation, slight time dilation, and alterations in thought patterns, making it useful for cognitive research.

• Common Dose (6–10 mg): This is the typical dose range for noticeable dissociation, sensory changes, and mood alterations in observational or behavioral research.

• High Dose (11–15 mg+): Leads to full dissociative states, depersonalization, visual distortions, and stronger effects on memory and coordination. Only used in advanced research under strict control.

• Route Matters: Oral and sublingual administration often requires higher doses due to first-pass metabolism, while intranasal use may have quicker onset with slightly lower quantities.

• Tolerance Concerns: Repeated use within short timeframes rapidly builds tolerance, which can skew research data. Adequate spacing between sessions is necessary.

• Safety Emphasis: All dosing should be performed with precise digital milligram scales. Estimating by eye is dangerous due to the compound’s potency.

The effects of 4-MeO-PCP are known to be long-lasting compared to many other dissociatives. Its duration can be broken into distinct phases: onset, peak, comedown, and afterglow. Total experience time can range between 4 to 12 hours depending on the dose, route, and individual factors.

• Onset (30–90 minutes): Effects typically begin within half an hour to 90 minutes post-administration. Oral and sublingual routes have a slower onset compared to intranasal.

• Peak Effects (2–4 hours): The most intense phase occurs during this window, with strong dissociation, altered perception, and time distortion. Sensory and cognitive changes are most profound here.

• Comedown (2–4 hours): Intensity tapers down gradually, with effects fading into a milder state. Users may regain motor control and clearer cognition while still feeling residual distortion.

• Afterglow (up to 12 hours): A subtle sense of calm, euphoria, or lingering cognitive shifts may be present. Some users report sleep difficulty during this phase.

• Total Duration: Depending on dose and metabolism, the full span can be 6 to 12 hours, with higher doses taking longer to resolve.

• Redosing Not Recommended: Re-dosing during the comedown can lead to unpredictable stacking of effects and extended dissociation beyond manageable levels.

• Individual Variability: Factors such as body weight, tolerance, liver metabolism, and concurrent food intake can significantly influence timing.

Standard drug tests, such as those used for employment or legal compliance, typically do not screen for 4-MeO-PCP. However, specialized toxicology panels may detect it, particularly if the test is tailored to dissociatives or arylcyclohexylamines.

• Not Included in Standard Panels: Typical 5-panel and 10-panel drug tests (screening for THC, opiates, cocaine, amphetamines, etc.) do not detect 4-MeO-PCP.

• Potential Cross-Reactivity: Some anecdotal reports suggest 4-MeO-PCP may cause false positives for PCP on extended panels due to structural similarity, though this is rare.

• Custom Testing: Specialized laboratories or forensic analysis using GC-MS (gas chromatography-mass spectrometry) or LC-MS (liquid chromatography-mass spectrometry) can identify it directly.

• Detection Window: Due to its long half-life and lipophilicity, traces may remain detectable in blood or urine for several days post-administration.

• Hair and Saliva Testing: These are unlikely to detect 4-MeO-PCP unless specifically designed to, though long-term retention in hair is theoretically possible.

• Legal Testing Considerations: In countries where 4-MeO-PCP is controlled, authorities may use advanced testing protocols during legal investigations.

• User Awareness: Researchers or consumers undergoing drug testing should exercise caution and be aware of local testing procedures if applicable.

Yes. Like all dissociatives, 4-MeO-PCP can produce a range of side effects that vary in intensity based on dose, individual sensitivity, and setting. While many effects are temporary, they can be intense and disorienting, especially at higher doses or with improper use.

• Cognitive Confusion: One of the most commonly reported side effects is difficulty forming coherent thoughts or speech during peak effects. This can interfere with decision-making.

• Memory Suppression: Short-term memory is often impaired during the experience, making it hard to recall events that occur while under the influence.

• Nausea and Dizziness: Especially at higher doses or with oral consumption, some users may experience gastrointestinal discomfort or balance issues.

• Emotional Blunting: Feelings of emotional detachment or reduced empathy are typical, which can persist into the afterglow phase in some cases.

• Elevated Heart Rate and Blood Pressure: Cardiovascular stimulation may occur, particularly in individuals with pre-existing conditions or at high doses.

• Anxiety or Paranoia: In some users, especially those unfamiliar with dissociatives, 4-MeO-PCP can trigger psychological discomfort or panic.

• Motor Impairment: Loss of coordination and muscle control is common and can increase the risk of falls or injuries if physical movement is attempted during peak states.

While 4-MeO-PCP does not produce classic physical withdrawal symptoms like opioids or alcohol, it does carry a potential for psychological dependence, especially with repeated or unsupervised use. Its euphoric and dissociative effects can be habit-forming for some individuals.

• Low Physical Dependence: There are no reported cases of physical withdrawal syndromes following cessation. This makes it less addictive than stimulants or depressants.

• Psychological Craving: Some users report a desire to revisit the dissociative escape or emotional numbing effects, which can lead to habitual use.

• Rapid Tolerance Build-Up: Repeated use over short intervals significantly reduces efficacy, leading to dose escalation—a known risk factor for dependency patterns.

• Cross-Tolerance with Other Dissociatives: Frequent use of 4-MeO-PCP may reduce sensitivity to related compounds like ketamine or DXM, complicating research or therapeutic use.

• Risk of Escapism: Users with underlying psychological issues may misuse the substance to avoid emotional distress, increasing dependence risks.

• Addiction Potential Rating: On comparative scales, its addiction potential is rated lower than opioids or stimulants but higher than classical psychedelics like LSD.

• Avoiding Dependence: Limiting frequency of use, measuring doses carefully, and maintaining clear intentions can help reduce dependency risk.

4-MeO-PCP is highly regarded in chemical and pharmacological research for its unique dissociative properties and relatively consistent effect profile. Unlike many unpredictable analogues, it offers reproducible outcomes, making it suitable for exploring NMDA receptor antagonism, consciousness studies, and neurobehavioral modeling.

• Stable Dissociative Profile: 4-MeO-PCP reliably induces dissociative states that can be analyzed across subjects. This consistency helps researchers design studies with more predictable results.

• Receptor Specificity: Its strong NMDA antagonism allows for the focused study of glutamatergic systems and their role in cognition, perception, and memory formation.

• Moderate Duration: The 4–8 hour active window offers enough time for detailed observation without the extended commitment of compounds like LSD or ibogaine.

• Less Chaotic than PCP: Its smoother cognitive profile reduces the likelihood of disruptive or erratic behavior in observational models, making it more manageable for clinical or lab environments.

• Reduced Physical Toxicity: Unlike some research chemicals with toxic metabolites, 4-MeO-PCP has shown no evidence of hepatotoxicity or neurotoxicity in moderate dosages based on anecdotal and limited in vitro findings.

• Dose-Response Clarity: It exhibits clear thresholds and plateaus in its effects, providing valuable pharmacokinetic data for developing models of NMDA receptor modulation.

• Availability of Analytical Standards: Reputable sources like Psycho Plug provide purity-verified material that meets requirements for reproducibility in experimental settings.

At Psycho Plug, we prioritize security and discretion in our payment methods. For this reason, we accept only alternative, encrypted, or untraceable payment channels to protect your financial identity and maintain privacy.

• Bitcoin (BTC): Our preferred payment method due to its anonymity, speed, and international accessibility. We provide a wallet address and guide for new crypto users.

• Zelle: Popular for U.S.-based buyers seeking instant, bank-linked transfers. Quick and easy, with no fees for most users.

• CashApp: A user-friendly option that allows seamless peer-to-peer payments. Particularly convenient for mobile users.

• Bank Transfer: Available for customers preferring direct deposits. Processing times may vary depending on your bank and location.

• Western Union: Suitable for users in regions where other methods are unavailable. Payments are collected in-person and confirmed manually.

• No Credit Card Option: Due to the nature of our products and privacy policies, we do not accept Visa, Mastercard, or PayPal to protect both you and us from unnecessary scrutiny.

• Step-by-Step Instructions: After checkout, we send detailed payment instructions to your email, including amounts, payment reference, and estimated confirmation time.

Yes, we stand by a 100% satisfaction guarantee and offer a customer-first refund and reshipment policy. We understand how important reliability is in this field, and we back every order with a risk-free promise.

• 30-Day Replacement Guarantee: If your package arrives damaged, incomplete, or not at all, we’ll send a free replacement—no extra charge.

• Refund Eligibility: You may request a full refund within 30 days if the product is returned unopened and in original condition.

• Lost in Transit: If tracking shows no delivery activity for over 7 days, we will investigate and reship the order after confirmation.

• Discreet Return Process: If a return is needed, we guide you through a safe and anonymous return method with no product names on return labels.

• Customer Service Support: Our team is available 7 days a week to assist with disputes, delivery issues, or order problems.

• Minimal Documentation Required: We don’t require long forms or intrusive questions. Just your order ID, brief explanation, and a photo (if applicable).

• Policy Exceptions: Refunds are not offered for confiscated items due to local law violations. Buyers must ensure legal compliance before purchase.

Yes, Psycho Plug provides worldwide shipping of 4-MeO-PCP and other research chemicals. We maintain strict standards of packaging, labeling, and discretion to ensure your order reaches you quickly and safely, regardless of your location.

• Global Coverage: We ship to over 80 countries across North America, Europe, Asia, Australia, and parts of Africa and South America.

• Discreet Packaging: All orders are double-sealed, vacuum-packed, and shipped in unmarked parcels with no logos, product names, or psychedelic references.

• Customs-Conscious Documentation: When necessary, we use generic labeling and customs documentation that complies with international trade laws.

• Carrier Flexibility: We work with DHL, USPS, FedEx, and other regional partners to optimize delivery speed and stealth.

• Tracking Numbers Included: Every shipment is trackable from dispatch to delivery. You’ll receive a tracking link as soon as the package leaves our warehouse.

• Risk Mitigation: In high-risk regions, we use extra layers of protection, including stealth labels and local forwarding agents where applicable.

• Buyer Responsibility: Customers must check their local import regulations. We cannot be held liable for customs seizures in regions where 4-MeO-PCP is explicitly banned.

While 4-MeO-PCP is less aggressive than PCP and slightly more forgiving than some of its analogues, it is not generally recommended for novice users without prior dissociative experience. Its effects can be intense, disorienting, and psychologically challenging at moderate doses.

• Steep Learning Curve: First-time users may find the dissociative states overwhelming, especially without preparation or controlled environments.

• Start Low and Slow: If used in research or experimentation, newcomers should begin with sub-threshold or microdoses to assess individual sensitivity.

• Cognitive Detachment: Feelings of depersonalization or unreality can be disturbing to those unfamiliar with dissociatives.

• Set and Setting Matter: Safe environments, calm mental states, and the presence of sober sitters are critical for risk mitigation.

• Not Ideal for Social Settings: It is better suited for private, introspective scenarios than parties or large groups due to its isolating nature.

• Impaired Coordination: Physical effects include imbalance and motor skill impairment, which can lead to injury if precautions aren’t taken.

• Tolerance Risks: New users are more likely to chase effects and redose too early, which can result in unexpectedly intense or prolonged experiences.